Dr. Suresh Poosala
Dr. Suresh Poosala is the Founder and President of OncoSeek Bio Pvt Ltd; Board of Directors, Reagene Biosciences; Advisor to The Jackson Laboratory; Council Member, AAALAC International, Strategic Advisor, Science in India, The Jackson Laboratory, USA Committee member-Antibiotic Residues, FSSAI, GOI, India Consultant for in vivo Regulatory and Facilities Accreditations, Pacific Rim Executive Member, Federation of Asian Biologists Association (FABA). He is a leader, scientist and motivator with three decades of international experience in fostering science, innovation and collaborative culture, by building and nurturing high-performing teams. His career spans scientific excellence in discovery and research, which resulted in high impact publications in high visibility international journals including Nature and he created exceptional quality in vivo facilities and created trained teams for R&D. He has succeeded as a leader in enabling great collaborations between CROs and Discovery programs, academia and industry, and between many strategic partners. He returned to India after 25 years at NIH, Washington, Bristol-Myers Squibb, San Francisco, University of Maryland, Baltimore, and St. Jude’s Research, Memphis. He launched a startup after his return to India and is participating in several active advisory roles and partnerships, his way of giving back to Science in India.
Prof P. Reddanna
Prof P. Reddanna, Senior Professor (Retd.) in the School of Life Sciences, University of Hyderabad, works in the area of inflammation and cancer, specifically in the drug discovery programs. Prof. Reddanna published around 200 papers in peer reviewed journals; Guided 40 students for Ph.D. and trained more than 150 students for M. Sc. Projects. He has successfully completed 25 projects funded by Government agencies like DST, DBT, CSIR, UGC and ICMR, and other International agencies. He also has undertaken projects from leading Pharma and Biotech companies like Dr. Reddy’s Labs, Dabur Research Foundation, Indian Immunologicals, Natco Pharma, Onconova Therapeutics, Surya Pharmaceuticals, etc.
He was the founder Director of National Institute of Animal Biotechnology (NIAB) of the Department of Biotechnology, Government of India (2010-2014). He served as the Dean of School of Life Sciences (Jan, 2015 to Jan, 2018) and member of Executive Council of University of Hyderabad. He has recently established state-of-the-art BioNEST incubation center for startup companies within the School of Life Sciences, University of Hyderabad (bionest.uohyd.ac.in). He is currently the Executive President of FABA.
Dr. Balaji Bhyravbhatla
Dr. Balaji Bhyravbhatla, is the Managing Director at HyLasCo Bio-Technology (India) Pvt. Ltd. Dr. Balaji, after his Ph.D in Biophysics from Brandies University started his career as post doc in Florida state University and later remained as a visiting faculty member in the Institute of Molecular Biophysics and played major role in facilities planning, setting up of infrastructure as well as training programs. Later, in 2001 he joined as faculty in University of Massachusetts medical school and instrumental in starting the research core in structural biology and training programs in structural biology in the Dept. of Biochemistry and Molecular Biology. He continued his research on large protein structures and mechanisms of oxygen transport using haemoglobin from various species as well as computational methods for solvent models and ligand binding. His technical expertise in early stage drug discovery and mechanism of action studies, small molecule characterization and API developments, analyzing patents and formulating IP strategies led him to co found XTAL Biostructures for structure guided drug discovery services. He led XTAL from its inception, first as VP for research and later as its CEO to a multimillion dollar self funded organically growing company. Recently he stepped down as the CEO of XTAL to start Hylasco Biotechnology in 2012 partnering with internationally reputed manufactures and suppliers of animal models and related services. His vision is to bring down the cost of drug discovery by providing appropriate animal models in a cost effective way to the Indian Pharma and Biotech sectors.
Harita Vasireddi is currently the Managing Director & Executive Director at Vimta Labs Ltd. She is also on the board of EMTAC Laboratories Pvt Ltd. She previously was Operations Manager at Vimta Rostest Pvt Ltd. She received an MBA from Boston College and an undergraduate degree from the University of Mysore.
Dr. Bharadwaja Vadloori
Dr. Bharadwaja Vadloori is a Senior Scientist at OncoseekBio Pvt Ltd, BioNEST Incubation Centre, School of Life Sciences, University of Hyderabad. He is a master in Biochemistry from Banaras Hindu University and a PhD in infection biology from University of Hyderabad.